Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease

• Main Authors: Tetsuhiro Yoshimura (Author), Keiichi Mitsuyama (Author), Ryosuke Sakemi (Author), Hidetoshi Takedatsu (Author), Shinichiro Yoshioka (Author), Kotaro Kuwaki (Author), Atsushi Mori (Author), Shuhei Fukunaga (Author), Toshihiro Araki (Author), Masaru Morita (Author), Kozo Tsuruta (Author), Hiroshi Yamasaki (Author), Takuji Torimura (Author)
• Format: Book
• Published: Hindawi Limited, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are scarce; the methods for estimating disease activity are less established, particularly for CD. This study is aimed at evaluating the util...